MDStephenJensikStephen Jensik349341Jensik, StephenC.My Scopus ID is 7004568893Assistant Professorprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifierbibo:suffixNamename suffixAddressvivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:middleNamemiddle name or initialvivo:overviewoverviewvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD007166Chemicals & Drugs571320.911178Immunosuppressive AgentsD061807Phenomena330.994196Catheter Obstructiontrue1ProfessorProfessorBrianColeBrian Cole41.87352120000000-87.66713820000000349060Cole, BrianProfessortrue1Associate ProfessorAssociate ProfessorInternal Medicine, CardiologyKernSinghKern Singh41.87352120000000-87.66713820000000349091Singh, KernAssociate ProfessorEdieChanEdie Chan349207Chan, EdieAssociate ProfessorRamiDoukkyRami Doukky349247Doukky, RamiProfessorSheilaEswaranSheila Eswaran349261Eswaran, SheilaAssistant ProfessorD006435Procedures421130.906507Renal DialysisSurgery1115selected publications0.778350.01052293research areas0.7731910.03274664coauthor of12.65291.7501160similar toOyedolamuOlaitanOyedolamu Olaitan349476Olaitan, OyedolamuAssistant ProfessorEdwardHollingerEdward Hollinger349560Hollinger, EdwardAssistant Professor6Assistant Professor5Associate Professor4Professor25382251Chan EY, Bhattacharya R, Eswaran S, Hertl M, Shah N, Fayek S, Cohen EB, Hollinger EF, Olaitan O, Jensik SC, Perkins JDClinical transplantationOutcomes after combined liver-kidney transplant vs. kidney transplant followed by liver transplant. Clin Transplant. 2015 Jan; 29(1):60-6.Clin Transplant2014-12-01T00:00:002014Outcomes after combined liver-kidney transplant vs. kidney transplant followed by liver transplant.Authorship 120447Authorship 126505Authorship 126647Authorship 140942Authorship 1538710Authorship 1687816D001166Procedures10190.974997Arteriovenous Shunt, SurgicalAuthorship 172462Authorship 181769Authorship 184926Authorship 20211515659146Peddi VR, Jensik S, Pescovitz M, Pirsch J, Adler SH, Thistlethwaite JR, Vincenti F, Cohen DJClinical transplantationAn open-label, pilot study evaluating the safety and efficacy of converting from calcineurin inhibitors to sirolimus in established renal allograft recipients with moderate renal insufficiency. Clin Transplant. 2005 Feb; 19(1):130-6.Clin Transplant2005-02-01T00:00:002005An open-label, pilot study evaluating the safety and efficacy of converting from calcineurin inhibitors to sirolimus in established renal allograft recipients with moderate renal insufficiency.16082323Mendez R, Gonwa T, Yang HC, Weinstein S, Jensik S, Steinberg STransplantationA prospective, randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 1 year. Transplantation. 2005 Aug 15; 80(3):303-9.Transplantation2005-08-15T00:00:002005A prospective, randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 1 year.17425744Cibrik D, Meier-Kriesche HU, Bresnahan B, Wu YM, Klintmalm G, Kew CE, Kuo PC, Whelchel J, Cohen D, Baliga P, Akalin E, Benedetti E, Wright F, Lieberman B, Ulbricht B, Jensik SClinical transplantationRenal function with cyclosporine C2 monitoring, enteric-coated mycophenolate sodium and basiliximab: a 12-month randomized trial in renal transplant recipients. Clin Transplant. 2007 Mar-Apr; 21(2):192-201.Clin Transplant2007-03-01T00:00:002007Renal function with cyclosporine C2 monitoring, enteric-coated mycophenolate sodium and basiliximab: a 12-month randomized trial in renal transplant recipients.20573162Gaber AO, Mulgaonkar S, Kahan BD, Woodle ES, Alloway R, Bajjoka I, Jensik S, Klintmalm GB, Patton PR, Wiseman A, Lipshutz G, Kupiec-Weglinski J, Gaber LW, Katz E, Irish W, Squiers EC, Hemmerich SClinical transplantationYSPSL (rPSGL-Ig) for improvement of early renal allograft function: a double-blind, placebo-controlled, multi-center Phase IIa study. Clin Transplant. 2011 Jul-Aug; 25(4):523-33.Clin Transplant2010-06-22T00:00:002010YSPSL (rPSGL-Ig) for improvement of early renal allograft function: a double-blind, placebo-controlled, multi-center Phase IIa study.23684413Ferral H, Behrens G, Tumer Y, Gueyikian SA, Hollinger EF, Jensik SCJournal of vascular surgeryBalloon-assisted over-the-wire technique for placement of the venous outflow component of the Hemodialysis Reliable Outflow (HeRO) device. J Vasc Surg. 2013 Oct; 58(4):1117-9.J Vasc Surg2013-05-16T00:00:002013Balloon-assisted over-the-wire technique for placement of the venous outflow component of the Hemodialysis Reliable Outflow (HeRO) device.24684771Hye RJ, Peden EK, O'Connor TP, Browne BJ, Dixon BS, Schanzer AS, Jensik SC, Dember LM, Jaff MR, Burke SKJournal of vascular surgeryHuman type I pancreatic elastase treatment of arteriovenous fistulas in patients with chronic kidney disease. J Vasc Surg. 2014 Aug; 60(2):454-461.e1.J Vasc Surg2014-03-27T00:00:002014Human type I pancreatic elastase treatment of arteriovenous fistulas in patients with chronic kidney disease.11884931Williams JW, Mital D, Chong A, Kottayil A, Millis M, Longstreth J, Huang W, Brady L, Jensik STransplantationExperiences with leflunomide in solid organ transplantation. Transplantation. 2002 Feb 15; 73(3):358-66.Transplantation2002-02-15T00:00:002002Experiences with leflunomide in solid organ transplantation.11907427Vincenti F, Jensik SC, Filo RS, Miller J, Pirsch JTransplantationA long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years. Transplantation. 2002 Mar 15; 73(5):775-82.Transplantation2002-03-15T00:00:002002A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years.12717205Gonwa T, Mendez R, Yang HC, Weinstein S, Jensik S, Steinberg STransplantationRandomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months. Transplantation. 2003 Apr 27; 75(8):1213-20.Transplantation2003-04-27T00:00:002003Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months.Authorship 413113Authorship 41480833249206Terranella S, Fefferman M, Zhang Y, Wright K, Hollinger E, Olaitan O, Hertl M, Jensik S, Keen R, Chan EJournal of vascular surgeryEconomic evaluation of suture versus clip anastomosis in arteriovenous fistula creation. J Vasc Surg. 2021 06; 73(6):2098-2104.J Vasc Surg2020-11-27T00:00:002020Economic evaluation of suture versus clip anastomosis in arteriovenous fistula creation.31509331Harland RC, Klintmalm G, Jensik S, Yang H, Bromberg J, Holman J, Kumar MSA, Santos V, Larson TJ, Wang XAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant SurgeonsEfficacy and safety of bleselumab in kidney transplant recipients: A phase 2, randomized, open-label, noninferiority study. Am J Transplant. 2020 01; 20(1):159-171.Am J Transplant2019-10-19T00:00:002019Efficacy and safety of bleselumab in kidney transplant recipients: A phase 2, randomized, open-label, noninferiority study.Neurological SciencesOrthopedic SurgeryRush University, Rush Medical CollegeDavidBennettDavid A. Bennett41.87328300000000-87.66936330000000349004Bennett, DavidProfessorAuthorship 44931635440378Chang J, Hejna EE, Terranella SL, Trawczynski MH, Hollinger EF, Jensik SC, Olaitan OK, Hertl M, Chan EYAmerican journal of surgeryGraft repair of arteriovenous fistula aneurysms is associated with decreased long-term patency. Am J Surg. 2022 07; 224(1 Pt A):136-140.Am J Surg2022-04-15T00:00:002022Graft repair of arteriovenous fistula aneurysms is associated with decreased long-term patency.true1Assistant ProfessorAssistant ProfessorInternal Medicine, Division of Digestive Diseases and NutritionAjaypalSinghAjaypal Singh349809Singh, AjaypalAssistant ProfessorD016030Procedures501250.863274Kidney Transplantationtrue1ProfessorProfessortrue1Assistant ProfessorAssistant ProfessorAuthorship 26313627986480Peden EK, O'Connor TP, Browne BJ, Dixon BS, Schanzer AS, Jensik SC, Sam AD, Burke SKJournal of vascular surgeryArteriovenous fistula patency in the 3?years following vonapanitase and placebo treatment. J Vasc Surg. 2017 Apr; 65(4):1113-1120.J Vasc Surg2016-12-13T00:00:002016Arteriovenous fistula patency in the 3?years following vonapanitase and placebo treatment.true1ProfessorProfessorAuthorship 45714636189749Hejna EE, Chang J, Terranella SL, Trawczynski MH, Hollinger EF, Jensik SC, Olaitan O, Hertl M, Chan EYThe journal of vascular accessEnd-to-end anastomosis as a superior repair type to prevent recurrence of arteriovenous fistula aneurysms and improve patency outcomes. J Vasc Access. 2022 Oct 02; 11297298221125609.J Vasc Access2022-10-02T00:00:002022End-to-end anastomosis as a superior repair type to prevent recurrence of arteriovenous fistula aneurysms and improve patency outcomes.true1Assistant ProfessorAssistant Professortrue1Assistant ProfessorAssistant Professortrue1Associate ProfessorAssociate Professortrue1Assistant ProfessorAssistant Professor